Spantide-induced antinociception in the opioid mechanism.
Tan-No
K
K
Department of Pharmacology, Tohoku College of Pharmacy, Sendai, Japan.
Sakurada
T
T
Yamada
T
T
Sakurada
S
S
Kisara
K
K
D000700:Analgesics / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D007278:Injections, Spinal; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009270:Naloxone / Q000378:metabolism* / Q000494:pharmacology; D010146:Pain / Q000503:physiopathology* / Q000517:prevention & control; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D013373:Substance P / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
D000700:Analgesics; D011957:Receptors, Opioid; D013373:Substance P; D009270:Naloxone; C042867:spantide